Titre : Calbindine-2

Calbindine-2 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Child Development
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Calbindine-2 : Questions médicales les plus fréquentes", "headline": "Calbindine-2 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Calbindine-2 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-21", "dateModified": "2025-03-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Calbindine-2" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Calbindines", "url": "https://questionsmedicales.fr/mesh/D064026", "about": { "@type": "MedicalCondition", "name": "Calbindines", "code": { "@type": "MedicalCode", "code": "D064026", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.125.090" } } }, "about": { "@type": "MedicalCondition", "name": "Calbindine-2", "alternateName": "Calbindin 2", "code": { "@type": "MedicalCode", "code": "D064032", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Eui-Man Jung", "url": "https://questionsmedicales.fr/author/Eui-Man%20Jung", "affiliation": { "@type": "Organization", "name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea." } }, { "@type": "Person", "name": "Yeong-Min Yoo", "url": "https://questionsmedicales.fr/author/Yeong-Min%20Yoo", "affiliation": { "@type": "Organization", "name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea." } }, { "@type": "Person", "name": "Eui-Bae Jeung", "url": "https://questionsmedicales.fr/author/Eui-Bae%20Jeung", "affiliation": { "@type": "Organization", "name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea, ebjeung@chungbuk.ac.kr." } }, { "@type": "Person", "name": "Seon Young Park", "url": "https://questionsmedicales.fr/author/Seon%20Young%20Park", "affiliation": { "@type": "Organization", "name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea." } }, { "@type": "Person", "name": "Changhwan Ahn", "url": "https://questionsmedicales.fr/author/Changhwan%20Ahn", "affiliation": { "@type": "Organization", "name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Maternal-infant bonding and partner support during pregnancy and postpartum: Associations with early child social-emotional development.", "datePublished": "2023-08-04", "url": "https://questionsmedicales.fr/article/37544195", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.infbeh.2023.101871" } }, { "@type": "ScholarlyArticle", "name": "Proximal determinants of suboptimal early child development during the first three years of life in socially deprived Mexican contexts.", "datePublished": "2023-11-02", "url": "https://questionsmedicales.fr/article/37917638", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0291300" } }, { "@type": "ScholarlyArticle", "name": "The benefits of nurturing care interventions on early child development and care: findings from a quasi-experimental study in a humanitarian setting.", "datePublished": "2023-08-24", "url": "https://questionsmedicales.fr/article/37620801", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12887-023-04239-z" } }, { "@type": "ScholarlyArticle", "name": "Roles of caregiver-child interaction on the association of socioeconomic status with early childhood development: a population-based study in rural China.", "datePublished": "2024-06-17", "url": "https://questionsmedicales.fr/article/38880881", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-024-18803-4" } }, { "@type": "ScholarlyArticle", "name": "Impact of interferon beta exposure on birth outcome and child development - Results from the post-authorisation safety study PRIMA.", "datePublished": "2023-06-24", "url": "https://questionsmedicales.fr/article/37393802", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.msard.2023.104844" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines de transport", "item": "https://questionsmedicales.fr/mesh/D002352" }, { "@type": "ListItem", "position": 5, "name": "Protéines de liaison au calcium", "item": "https://questionsmedicales.fr/mesh/D002135" }, { "@type": "ListItem", "position": 6, "name": "Calbindines", "item": "https://questionsmedicales.fr/mesh/D064026" }, { "@type": "ListItem", "position": 7, "name": "Calbindine-2", "item": "https://questionsmedicales.fr/mesh/D064032" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Calbindine-2 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Calbindine-2", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Calbindine-2", "description": "Comment diagnostiquer une carence en calbindine-2 ?\nQuels examens sont utilisés pour évaluer la calbindine-2 ?\nLa calbindine-2 est-elle mesurable dans le sang ?\nQuels symptômes peuvent indiquer un problème avec la calbindine-2 ?\nY a-t-il des marqueurs spécifiques pour la calbindine-2 ?", "url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Child+Development&page=8#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Calbindine-2", "description": "Quels sont les symptômes d'une déficience en calbindine-2 ?\nLa calbindine-2 affecte-t-elle le système nerveux ?\nDes douleurs musculaires peuvent-elles être liées à la calbindine-2 ?\nLa fatigue est-elle un symptôme associé à la calbindine-2 ?\nPeut-on observer des troubles cognitifs liés à la calbindine-2 ?", "url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Child+Development&page=8#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Calbindine-2", "description": "Comment prévenir une carence en calbindine-2 ?\nLes suppléments de calcium sont-ils nécessaires ?\nY a-t-il des groupes à risque pour la calbindine-2 ?\nL'exposition au soleil est-elle importante ?\nDes tests réguliers sont-ils conseillés ?", "url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Child+Development&page=8#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Calbindine-2", "description": "Comment traiter une carence en calbindine-2 ?\nY a-t-il des médicaments pour réguler la calbindine-2 ?\nLa physiothérapie aide-t-elle en cas de dysfonction de la calbindine-2 ?\nDes changements alimentaires peuvent-ils aider ?\nLes exercices physiques sont-ils bénéfiques ?", "url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Child+Development&page=8#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Calbindine-2", "description": "Quelles complications peuvent survenir avec une carence en calbindine-2 ?\nLa calbindine-2 est-elle liée à des maladies chroniques ?\nDes troubles de l'humeur peuvent-ils être liés à la calbindine-2 ?\nLa calbindine-2 influence-t-elle le développement cognitif ?\nY a-t-il un risque accru de chutes ?", "url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Child+Development&page=8#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Calbindine-2", "description": "Quels facteurs augmentent le risque de carence en calbindine-2 ?\nLes troubles métaboliques sont-ils un facteur de risque ?\nLe mode de vie sédentaire influence-t-il la calbindine-2 ?\nLes régimes restrictifs sont-ils risqués ?\nLes antécédents familiaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Child+Development&page=8#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en calbindine-2 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des biopsies musculaires peuvent aider à évaluer les niveaux de calbindine-2." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer la calbindine-2 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'électrophorèse des protéines et l'immunohistochimie sont couramment utilisés." } }, { "@type": "Question", "name": "La calbindine-2 est-elle mesurable dans le sang ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, la calbindine-2 est principalement présente dans les tissus, pas dans le sang." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec la calbindine-2 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles neurologiques ou musculaires peuvent suggérer un dysfonctionnement de la calbindine-2." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour la calbindine-2 ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme la calmoduline peuvent être évalués en relation avec la calbindine-2." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en calbindine-2 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des spasmes musculaires, des tremblements et des troubles de la coordination." } }, { "@type": "Question", "name": "La calbindine-2 affecte-t-elle le système nerveux ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle joue un rôle crucial dans la transmission synaptique et la plasticité neuronale." } }, { "@type": "Question", "name": "Des douleurs musculaires peuvent-elles être liées à la calbindine-2 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une dysfonction de la calbindine-2 peut entraîner des douleurs musculaires et des crampes." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme associé à la calbindine-2 ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une fatigue excessive peut résulter d'une mauvaise régulation du calcium par la calbindine-2." } }, { "@type": "Question", "name": "Peut-on observer des troubles cognitifs liés à la calbindine-2 ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en raison de l'implication de la calbindine-2 dans le cerveau." } }, { "@type": "Question", "name": "Comment prévenir une carence en calbindine-2 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et des contrôles réguliers de la santé peuvent aider." } }, { "@type": "Question", "name": "Les suppléments de calcium sont-ils nécessaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être recommandés, surtout pour les personnes à risque de carence." } }, { "@type": "Question", "name": "Y a-t-il des groupes à risque pour la calbindine-2 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées et celles avec des troubles métaboliques sont plus à risque." } }, { "@type": "Question", "name": "L'exposition au soleil est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition au soleil aide à la synthèse de la vitamine D, essentielle pour la calbindine-2." } }, { "@type": "Question", "name": "Des tests réguliers sont-ils conseillés ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests réguliers peuvent aider à détecter précocement des anomalies." } }, { "@type": "Question", "name": "Comment traiter une carence en calbindine-2 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des suppléments de calcium et des thérapies ciblées." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour réguler la calbindine-2 ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de médicaments spécifiques pour la calbindine-2." } }, { "@type": "Question", "name": "La physiothérapie aide-t-elle en cas de dysfonction de la calbindine-2 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut améliorer la force musculaire et la coordination." } }, { "@type": "Question", "name": "Des changements alimentaires peuvent-ils aider ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en calcium et en vitamine D peut soutenir la fonction de la calbindine-2." } }, { "@type": "Question", "name": "Les exercices physiques sont-ils bénéfiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des exercices réguliers peuvent améliorer la santé musculaire et nerveuse." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une carence en calbindine-2 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et musculaires graves peuvent se développer." } }, { "@type": "Question", "name": "La calbindine-2 est-elle liée à des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'ostéoporose peuvent être exacerbées par une carence en calbindine-2." } }, { "@type": "Question", "name": "Des troubles de l'humeur peuvent-ils être liés à la calbindine-2 ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres de calcium peuvent affecter l'humeur et le comportement." } }, { "@type": "Question", "name": "La calbindine-2 influence-t-elle le développement cognitif ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une déficience peut nuire au développement cognitif, surtout chez les enfants." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de chutes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une faiblesse musculaire due à une carence en calbindine-2 augmente le risque de chutes." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de carence en calbindine-2 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, une mauvaise alimentation et certaines maladies augmentent le risque." } }, { "@type": "Question", "name": "Les troubles métaboliques sont-ils un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme le diabète peuvent affecter les niveaux de calbindine-2." } }, { "@type": "Question", "name": "Le mode de vie sédentaire influence-t-il la calbindine-2 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut contribuer à une faiblesse musculaire et à des carences." } }, { "@type": "Question", "name": "Les régimes restrictifs sont-ils risqués ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les régimes restrictifs peuvent entraîner des carences en nutriments essentiels, y compris le calcium." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles musculaires ou neurologiques peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

The benefits of nurturing care interventions on early child development and care: findings from a quasi-experimental study in a humanitarian setting.

The study objective was to determine if a nurturing care parenting intervention delivered in a humanitarian setting in Rwanda would benefit early development, learning, and care outcomes for young chi... Rwanda's Mugombwa, Kansi, and Kigeme refugee camps and host communities implemented the parenting program. Via a quasi-experimental research design, the study assessed the effects of intervention deli... The assessment included 733 children and families in total: HD = 314, LD = 240, control = 179. The researchers found no significant difference in child development scores between the intervention and ... Parenting programmes in humanitarian settings can improve nurturing care practices, even with a low dose, which is essential to strengthening children's resilience in at-risk conditions. Further studi...

Roles of caregiver-child interaction on the association of socioeconomic status with early childhood development: a population-based study in rural China.

Socioeconomic status (SES) has been previously associated with children's early development, health, and nutrition; however, evidence about the potential role of caregiver-child interaction in such as... A cross-sectional survey was conducted among 2078 children aged 0-6 in a rural county that just lifted out of poverty in 2020 in Central China. The Ages & Stages Questionnaires-Chinese version (ASQ-C)... Children with low SES had an increased risk of suspected neurodevelopmental delay [OR = 1.92, 95% CI: 1.50, 2.44] and social-emotional developmental delay [OR = 1.31, 95% CI: 1.04, 1.66]. The caregive... Caregiver-child interaction plays a vital role in the relationship between SES and child development. Children with low SES households will benefit more in terms of their early development from interv...

Impact of interferon beta exposure on birth outcome and child development - Results from the post-authorisation safety study PRIMA.

Interferon beta therapies are well-established disease-modifying treatments for patients with relapsing multiple sclerosis (MS). Based on clinical evidence from two large cohort studies, both, the EMA... The post-authorisation safety study PRIMA included adult women diagnosed with relapsing-remitting MS or clinically isolated syndrome, who were treated with peginterferon beta-1a or IM interferon beta-... In total, 426 women were enrolled, reporting 542 pregnancies that resulted in 466 live births. A total of 162 women completed the questionnaire for 192 live births (53.1% male). Newborns had Apgar sco... Study results confirmed former reports indicating that exposure to interferon beta therapies during pregnancy or lactation had no adverse effects on intrauterine growth and child development over the ... NCT04655222, EUPAS38347....

Cohort profile update: The Canadian Maternal-Infant Research on Environmental Chemicals Child Development study (MIREC-CD PLUS).

The pan-Canadian Maternal-Infant Research on Environmental Chemicals (MIREC) study was established to determine whether maternal environmental chemical exposures were associated with adverse pregnancy... The MIREC-Child Development (CD PLUS) study followed this cohort with the goal of assessing the potential effects of prenatal exposures on anthropometry and neurodevelopment in early childhood.... MIREC families with children between the ages of 15 months and 5 years who had agreed to be contacted for future research (n = 1459) were invited to participate in MIREC-CD PLUS which combines data co... Between April 2013 and March 2015, 803 children participated in the Biomonitoring visit where we collected anthropometric measures, blood, and urine from the children. The Behavioural Assessment Syste... Data collection for the MIREC-CD PLUS study is complete and analysis of the data continues. We are now extending the follow-up of the cohort into adolescence to measure the impact of early life exposu...

Maternal metabolic syndrome in pregnancy and child development at age 5: exploring mediating mechanisms using cord blood markers.

There is limited evidence on how the classification of maternal metabolic syndrome during pregnancy affects children's developmental outcomes and the possible mediators of this association. This study... Maternal cardiometabolic markers included diabetes, obesity, triglycerides, high-density lipoprotein cholesterol, blood pressure, hypertension, and fasting glucose during pregnancy. Cord blood markers... In mediation models, significant total effects were found for MetS associations with children's development in the LIT domain at age 5. MetS predicted individual cord blood mediators of lower HDL and ... The results support the hypothesis that maternal metabolic syndrome classification during pregnancy is associated with some child developmental outcomes at age 5. After adjusting for maternal, child, ...

Effectiveness of an integrated multilevel early child development intervention on caregiver knowledge and behavior: a quasi-experimental evaluation of the Malezi program in Tanzania.

The quality of caregiving and the parent-child relationship is critical for early child development (ECD) and has been shown to be modifiable. This study evaluated an ECD project in Tanzania, assessin... This two-arm pre-post evaluation study enrolled a cohort of caregivers of children 0-24 months in four districts of Tabora region, following them for 9 months. ECD radio messages were broadcast on pop... In the RMV-ECD arm, all outcomes at endline except environment safety significantly improved after the intervention with the largest change seen in ECD knowledge (35.8% increase, p < .0001) and the sm... An intervention that includes mass media, educational video content and CHWs who counsel caregivers in their homes and health facilities was associated with significant improvements in ECD parenting k... NCT05244161 (17/02/2022); retrospectively registered with the US National Institutes of Health ClinicalTrials.gov....

The impact of interactive book sharing on child cognitive and socio-cognitive development (the REaL trial): study protocol for a randomized controlled trial.

The quality of children's early home learning environment has an influence on their cognitive development, preliteracy skills, and subsequent educational outcomes. Early intervention programs that pro... We have conducted a randomized controlled trial to evaluate the effects of a parent-child interactive book sharing intervention on early child language, cognition, and parental behaviors. Participatin... The Roadmap to Executive function and Language (REaL) trial aims to evaluate the impact of a brief early parenting intervention on key factors for child development, including child cognition and pare... The REaL trial is registered on the International Standard Randomized Controlled Trial Number database, registration number ISRCTN22319305. Retrospectively registered on 7 February 2020....

Association between maternal caffeine intake during pregnancy and child development at 6 and 12 months: The Japan Environment and Children's Study.

Caffeine intake by pregnant women may have neurodevelopmental effects on the fetus due to adenosine antagonism. However, there are insufficient data and inconsistent results from epidemiological studi... This study examined the association between mothers' estimated caffeine intake during pregnancy and their children's score on the Japanese version of the Ages & Stages Questionnaires™ (J-ASQ) at 6 and... The study is a part of nationwide prospective birth-cohort study: the Japan Environment and Children's Study.... In total, 87,106 participants with the Food Frequency Questionnaire (FFQ) data and J-ASQ at 6 or 12 months of age were included in the study.... The data were analyzed by logistic regression analysis to determine whether the scores of the five subscales on the J-ASQ were below the cutoff point as the dependent variable.... The results showed that children born to mothers who consumed >300 mg caffeine per day had a 1.11-fold increased odds of gross motor developmental delay at 12 months of age (adjusted odds ratio [AOR] ... Issues in gross motor development can emerge prior to future developmental issues. Therefore, further studies on developmental outcomes in older children, including the future outcomes of the children...